Stocktoria

OMEROS CORP OMER

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2009-10-08 · LEI

OMEROS CORP statistics & valuation

Market cap$627.5M
Net debt$78.2M
Enterprise value USD$705.7M
Earnings yield EBIT/EV-17.4%
Return on capital-49.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-130.40% -67.70% -375.70% -130.60% -212.60% 2016201720182019202020212022202320242025
Return on equity (%)
816.80% 55.30% 2016201720182019202020212022202320242025
Shares outstanding
43.8M 48.2M 49.0M 54.2M 61.7M 62.6M 62.8M 62.7M 58.2M 71.7M 2016201720182019202020212022202320242025
Net debt ($)
$78.3M $80.7M $155.1M $225.8M $212.7M $304.3M $206.1M $161.5M $78.2M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-99.20% -46.00% -132.10% -61.70% -76.30% 46.30% 8.00% -31.10% -56.60% -1.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-124.10% -56.40% -349.20% -54.00% -136.00% 2016201720182019202020212022202320242025
Debt / equity (×)
13.18× 3.68× 2016201720182019202020212022202320242025
EPS ($)
-$1.71 -$2.41 $3.12 $0.76 -$1.88 -$2.70 -$0.05 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-212.6%-130.6%-375.7%-67.7%-130.4%
Net margin-187.0%-75.6%-424.4%-82.5%-160.4%
FCF margin-136.0%-54.0%-349.2%-56.4%-124.1%
Return on assets-1.0%-56.6%-31.1%8.0%46.3%-76.3%-61.7%-132.1%-46.0%-99.2%
Return on equity2.8%85.9%471.6%55.3%816.8%114.3%77.5%126.6%1900.5%178.2%
Debt / equity-0.73×-0.90×-8.53×3.68×13.18×-1.96×-1.45×-29.89×-2.15×
Current ratio2.761.694.093.254.794.121.872.414.123.75

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.